Diabetes Research Program Publications | NYU Langone Health

Skip to Main Content
Diabetes Research Program Diabetes Research Program Publications

Diabetes Research Program Publications

Members of NYU Langone’s Diabetes Research Program regularly publish in leading peer-reviewed journals.

The receptor for advanced glycation end products and its ligands' expression in OVE26 diabetic sciatic nerve during the development of length-dependent neuropathy

Zglejc-Waszak, Kamila; Schmidt, Ann Marie; Juranek, Judyta K

Neuropathology. 2022 Aug 01;

Aldose reductase promotes diet-induced obesity via induction of senescence in subcutaneous adipose tissue

Thiagarajan, Devi; Quadri, Nosirudeen; Jawahar, Shabnam; Zirpoli, Hylde; Del Pozo, Carmen Hurtado; López-Díez, Raquel; Hasan, Syed Nurul; Yepuri, Gautham; Gugger, Paul F; Finlin, Brian S; Kern, Philip A; Gabbay, Kenneth; Schmidt, Ann Marie; Ramasamy, Ravichandran

Obesity (Silver Spring). 2022 Aug ; 30:1647-1658

Soluble Receptor for Advanced Glycation End Products (sRAGE) Isoforms Predict Changes in Resting Energy Expenditure in Adults with Obesity during Weight Loss

Popp, Collin J; Zhou, Boyan; Manigrasso, Michaele B; Li, Huilin; Curran, Margaret; Hu, Lu; St-Jules, David E; Alemán, José O; Vanegas, Sally M; Jay, Melanie; Bergman, Michael; Segal, Eran; Sevick, Mary A; Schmidt, Ann M

Current developments in nutrition. 2022 May ; 6:nzac046

The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications

Ramasamy, Ravichandran; Shekhtman, Alexander; Schmidt, Ann Marie

International journal of molecular sciences. 2022 Apr 21; 23:

Neuronal-glial communication perturbations in murine SOD1G93A spinal cord

MacLean, Michael; López-Díez, Raquel; Vasquez, Carolina; Gugger, Paul F; Schmidt, Ann Marie

Communications biology. 2022 02 28; 5:177

Glycation and a Spark of ALEs (Advanced Lipoxidation End Products) - Igniting RAGE/Diaphanous-1 and Cardiometabolic Disease

Arivazhagan, Lakshmi; López-Díez, Raquel; Shekhtman, Alexander; Ramasamy, Ravichandran; Schmidt, Ann Marie

Frontiers in cardiovascular medicine. 2022 Jul ; 9:937071

Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice

Manigrasso, Michaele B; Rabbani, Piul; Egaña-Gorroño, Lander; Quadri, Nosirudeen; Frye, Laura; Zhou, Boyan; Reverdatto, Sergey; Ramirez, Lisa S; Dansereau, Stephen; Pan, Jinhong; Li, Huilin; D'Agati, Vivette D; Ramasamy, Ravichandran; DeVita, Robert J; Shekhtman, Alexander; Schmidt, Ann Marie

Science translational medicine. 2021 Nov 24; 13:eabf7084

A pilot open-label study of aldose reductase inhibition with AT-001 (caficrestat) in patients hospitalized for COVID-19 infection: Results from a registry-based matched-control analysis

Gaztanaga, Juan; Ramasamy, Ravichandran; Schmidt, Ann Marie; Fishman, Glenn; Schendelman, Shoshana; Thangavelu, Karthinathan; Perfetti, Riccardo; Katz, Stuart D

Diabetes & metabolic syndrome. 2021 Oct 30; 15:102328